| Financial Year |
March 31 2023 |
| Monetary Funds |
1,907,430,230.42 |
| Held-for-trading Financial Assets |
288,731,594.09 |
| Notes Receivable |
2,563,233.65 |
| Accounts Receivable |
168,779,779.75 |
| Advances to Suppliers |
41,626,767.43 |
| Other Receivables |
48,661,495.71 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
865,985,776.80 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
102,717,247.01 |
| Total Current Assets |
3,437,824,240.93 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
6,691,424.24 |
| Investment Properties |
-- |
| Fixed Assetes |
1,979,791,852.49 |
| Under-construction Projects |
267,936,942.34 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,516,227,742.48 |
| R&D expenses |
23,109,126.66 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
57,079,576.50 |
| Deferred Income Tax Assets |
183,304,131.07 |
| Other Non-Current Assets |
14,786,824.12 |
| Sub-Total of Non-Current Assets |
4,496,118,379.82 |
| Total Assets |
7,933,942,620.75 |
| Short-Term Loans |
1,262,450,328.94 |
| Trading Financial liabilities |
-- |
| Notes Payable |
230,053,667.98 |
| Accounts Payable |
339,887,194.59 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
59,784,849.79 |
| Taxes Payable |
45,270,812.65 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
688,134,699.14 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
94,982,663.34 |
| Other Current Liabilities |
90,829,848.47 |
| Sub-Total of Current Liabilities |
3,518,559,441.72 |
| Long-term Loans |
511,320,575.16 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
2,558,549.05 |
| Deferred Income Tax Liabilities |
22,466,765.64 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
930,064,575.43 |
| Total Liabilities |
4,448,624,017.15 |
| Paid-In Capital(Or Share Stock) |
198,675,000.00 |
| Capital Surplus |
1,500,458,811.11 |
| Surplus Reserve |
88,044,295.41 |
| LESS:Treasury Stock |
49,998,642.09 |
| Undistributed Profits |
1,748,864,178.45 |
| Minority Stockholder's Interest |
-725,039.28 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,486,043,642.88 |
| Owner's Equity（Stockholder's Equity） |
3,485,318,603.60 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,933,942,620.75 |
